On 28 February 2023, Knowledge Ecology International (KEI) delivered the following statement on the zero draft prepared by the Bureau of the Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention,… Continue Reading
On February 14, 2023, USDOJ filed a Statement of Interest of the United States, in the patent dispute between Arbutus Biopharma, Genevant Sciences, and Moderna. A copy of the filing is here: arbutus.moderna.USG.statementofinterest This is an important, and while not… Continue Reading
UPDATED: On 10 February 2023, the Bureau of the WHO Intergovernmental Negotiating Body (INB) circulated to WHO member states a proposal for consideration by the INB regarding modalities for upcoming INB meetings (INB4/5), including the “Zero Draft” and “First Draft”… Continue Reading
On February 6, 2023, Knowledge Ecology International submitted comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Small Cell Lung Cancer Subtyping Using Plasma Cell-Free Nucleosomes” (88 FR 3749). The technology was… Continue Reading
On Wednesday, 1 February 2023, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, Public Services International, and the World Council of Churches on the following topic: “Universal Health Coverage – Reorienting health… Continue Reading
WHO-zero-draft-pandemic-treaty-1Feb2023 There is much to like in this draft on topics such as intellectual property rights, transparency, benefit sharing and equity. Easy to see why big drug companies have been alarmed at the direction of the WHO work on this.… Continue Reading